Federal Health Grants

This grant provides funding for innovative and high-risk research projects in biomedical, behavioral, or clinical fields, aimed at early-stage ideas that could lead to significant advancements.

This grant provides funding for nonprofit organizations and higher education institutions to create hands-on research projects that engage public health students in studying and addressing drug control policies and trends.

This funding opportunity supports researchers in discovering and validating new targets for developing safe and effective pain treatments with minimal side effects and low addiction risk.

This funding opportunity provides financial support to rural healthcare organizations in the Delta region to improve service delivery, enhance sustainability, and expand access to care through specific projects.

This funding opportunity provides financial support to state governments and U.S. territories to improve access to HIV care and treatment for low-income individuals living with HIV.

The National Human Genome Research Institute (NHGR) intends to promote a new initiative by publishing a Notice of Funding Opportunity (NOFO) to advance scholarship on the ethical, legal, and social implications (ELSI) of advances in human genetics or genomics, enhance ELSI research teams, build ELSI research capacity, and broaden the ELSI workforce.The intended NOFO will be based on aconceptrecently approved by the National Advisory Council on Human Genome Research and accompanyingdiscussion. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects, and to consult with NIH following release of the intended NOFO to submit responsive applications. The NOFO is expected to be published in summer of 2004 with an expected application due date in fall of 2024. This NOFO will utilize the UM1 activity code (Research Project with Complex Structure, Cooperative Agreement, Clinical Trial Optional). Details of the planned NOFO are provided below.

The purpose of this Notice of Funding Opportunity (NOFO) is to solicit applications for Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRCs). These Centers promote collaborative basic, translational, and clinical research and provide important resources that can be used by the national muscular dystrophy research community. A goal of this Centers program is to support important and innovative research in the muscular dystrophies that is best pursued through an interdisciplinary and collaborative center environment and projects that may not be as effective if supported by "stand-alone" research project grants. The Centers also provide outstanding environments for the training of new scientists electing to pursue careers conducting research in high priority areas of muscular dystrophy. Finally, Center investigators are expected to engage the patient and advocacy communities in conversations to increase awareness of research, encourage patient participation in research, and incorporate the perspectives of these communities in the conduct of patient-centered research.

This Funding Opportunity Announcement (FOA) will support extramural research to investigate and mitigate challenges facing clinical assay development and subsequent analytical validation due to preanalytical variability in tumor tissue biopsies, blood biospecimens utilized as liquid biopsies", or other biospecimens as described in this FOA. Extramural research funded under this FOA may include investigations of preanalytical variability associated with the procurement and study of small biopsies (core biopsies, small excision samples), blood utilized for "liquid biopsies", tissue swabs, tissue secretions, pleural and esophageal aspirates, feces, or bodily fluids like sweat, urine, CSF, breast milk and saliva. Investigator-designed experiments will explore how different biospecimen preanalytical conditions affect emerging and clinically relevant biomarkers quantified by a variety of testing platforms. The results from this research program will improve the understanding of how analytical quantification of clinically relevant biomarkers is affected by variation in biospecimen collection, processing, and storage procedures. The overall goal is to expedite biomarker clinical assay development through evidence-based standardization of biopsy handling practices.

The "Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer" grant aims to fund preliminary research into how the human microbiome affects the body's immune response to cancer, with a focus on how specific microbes or their byproducts can either increase or prevent tumor formation, and how the amount, timing, and duration of beneficial microbes can impact their effectiveness.

This funding opportunity provides financial support to state and territorial organizations that promote mental health recovery through peer-run programs for individuals with serious mental illness or emotional disturbances.

This funding opportunity supports the development of a national data resource center to improve research on childhood cancers and congenital anomalies, encouraging collaboration among a wide range of organizations and researchers.

This funding opportunity provides financial support for educational programs that train new researchers in Down syndrome to improve understanding and treatment of co-occurring health conditions throughout the lifespan.

This funding opportunity provides financial support to state and local governments for improving surveillance and data collection on violent deaths, enabling them to develop effective prevention strategies tailored to their communities.

This funding opportunity supports small businesses in conducting early-stage clinical trials for innovative treatments of vision-related disorders, ensuring safety and collaboration with the National Eye Institute.

This grant provides funding for researchers at U.S. institutions to explore innovative uses of nanotechnology in cancer research, focusing on improving targeted delivery and diagnostic capabilities for specific cancer types.

The purpose of this Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions is to support small scale research grants at institutions that do not receive substantial funding from the NIH, with an emphasis on providing biomedical research experiences primarily for undergraduate students, and enhancing the research environment at these applicant institutions. Eligible institutions must award baccalaureate science degrees, and have received less than 6 million dollars per year of NIH support (total costs) in 4 of the last 7 fiscal years.

This funding opportunity supports research institutions and organizations in developing and testing new treatments and recovery methods for individuals with alcohol use disorder, particularly focusing on underserved populations and innovative approaches.

The "Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research" grant aims to encourage current NCI R01 research projects to incorporate new technologies from the NCI Innovative Molecular Analysis Technologies program, with the goal of enhancing their original research and speeding up scientific discoveries in cancer research.

This funding opportunity provides financial support to organizations working in Zambia to improve HIV and TB prevention, care, and treatment services through innovative and sustainable quality improvement strategies.

This funding opportunity supports U.S.-based organizations in developing a centralized hub to advance the use of artificial intelligence and technology in research related to aging and Alzheimer's Disease, fostering collaboration and stakeholder engagement across multiple projects.